Semnur Pharmaceuticals, Inc. (SMNR)
0.55
0.00 (0.00%)
USD |
OTCM |
Aug 31, 16:00
Semnur Pharmaceuticals Net Income (Quarterly) : -4.347M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -4.347M |
| March 31, 2026 | -4.576M |
| December 31, 2025 | -6.158M |
| September 30, 2025 | -152.59M |
| June 30, 2025 | -0.999M |
| March 31, 2025 | -0.665M |
| December 31, 2024 | -0.776M |
| September 30, 2024 | -1.298M |
| June 30, 2024 | 0.4489M |
| Date | Value |
|---|---|
| March 31, 2024 | 0.2643M |
| December 31, 2023 | 0.5533M |
| September 30, 2023 | 0.6306M |
| June 30, 2023 | 0.4577M |
| March 31, 2023 | -1.009M |
| December 31, 2022 | -0.6847M |
| September 30, 2022 | 0.3075M |
| June 30, 2022 | -0.0308M |
| March 31, 2022 | -0.0113M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Scilex Holding Co. | -116.22M |
| ANI Pharmaceuticals, Inc. | 23.00M |
| Corcept Therapeutics, Inc. | 42.14M |
| Veru, Inc. | -6.988M |
| Johnson & Johnson | 5.534B |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 4.347M |
| EPS Diluted (Quarterly) | -0.0189 |
| Enterprise Value | 149.63M |
| Earnings Yield | -149.5% |
| Normalized Earnings Yield | -149.47 |